Summary Of Adalimumab-Api-Biologics & Biosimilars

Chemical Name

Adalimumab

CAS No.

331731-18-1

Molecular Formula

C20H22N2O7S

Innovator

Developer

Indication

Atopic Dermatitis; Crohns Disease; Melanoma; Rheumatoid Arthritis

Therapeutic Area

Dermatology; Digestive System Disease; Oncology; Immunology

Market Status

Launched

Approval Year

Patent Expiry